Literature DB >> 17092472

Cockayne syndrome in adults: review with clinical and pathologic study of a new case.

Isabelle Rapin1, Karen Weidenheim, Yelena Lindenbaum, Pearl Rosenbaum, Saumil N Merchant, Sindu Krishna, Dennis W Dickson.   

Abstract

Cockayne syndrome and xeroderma pigmentosum-Cockayne syndrome complex are rare autosomal recessive disorders with poorly understood biology. They are characterized by profound postnatal brain and somatic growth failure and by degeneration of multiple tissues resulting in cachexia, dementia, and premature aging. They result in premature death, usually in childhood, exceptionally in adults. This study compares the clinical course and pathology of a man with Cockayne syndrome group A who died at age 31(1/2) years with 15 adequately documented other adults with Cockayne syndrome and 5 with xeroderma pigmentosum-Cockayne syndrome complex. Slowing of head and somatic growth was apparent before age 2 years, mental retardation and slowly progressive spasticity at 4 years, ataxia and hearing loss at 9 years, visual impairment at 14 years, typical Cockayne facies at 17 years, and cachexia and dementia in his twenties, with a retained outgoing personality. He experienced several transient right and left hemipareses and two episodes of status epilepticus following falls. Neuropathology disclosed profound microencephaly, bilateral old subdural hematomas, white-matter atrophy, tigroid leukodystrophy with string vessels, oligodendrocyte proliferation, bizarre reactive astrocytes, multifocal dystrophic calcification that was most marked in the basal ganglia, advanced atherosclerosis, mixed demyelinating and axonal neuropathy, and neurogenic muscular atrophy. Cellular degeneration of the organ of Corti, spiral and vestibular ganglia, and all chambers of the eye was severe. Rarely, and for unexplained reasons, in some patients with Cockayne syndrome the course is slower than usual, resulting in survival into adulthood. The profound dwarfing, failure of brain growth, cachexia, selectivity of tissue degeneration, and poor correlation between genotypes and phenotypes are not understood. Deficient repair of DNA can increase vulnerability to oxidative stress and play a role in the premature aging, but why patients with mutations in xeroderma pigmentosum genes present with the Cockayne syndrome phenotype is still not known.

Entities:  

Mesh:

Year:  2006        PMID: 17092472      PMCID: PMC2772653          DOI: 10.1177/08830738060210110101

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  69 in total

1.  Cockayne's Syndrome: case report of a successful pregnancy.

Authors:  Soma Lahiri; Norman Davies
Journal:  BJOG       Date:  2003-09       Impact factor: 6.531

Review 2.  Ocular manifestations in the inherited DNA repair disorders.

Authors:  Hélène Dollfus; Fernanda Porto; Patrick Caussade; Claude Speeg-Schatz; José Sahel; Edouard Grosshans; Jacques Flament; Alain Sarasin
Journal:  Surv Ophthalmol       Date:  2003 Jan-Feb       Impact factor: 6.048

Review 3.  Mitochondrial respiratory-chain diseases.

Authors:  Salvatore DiMauro; Eric A Schon
Journal:  N Engl J Med       Date:  2003-06-26       Impact factor: 91.245

4.  Dwarfism with retinal atrophy and deafness.

Authors:  E A Cockayne
Journal:  Arch Dis Child       Date:  1936-02       Impact factor: 3.791

5.  Cockayne's syndrome. Report of case with necropsy findings.

Authors:  U Rowlatt
Journal:  Acta Neuropathol       Date:  1969-09-09       Impact factor: 17.088

Review 6.  Mitochondria, NO and neurodegeneration.

Authors:  M F Beal
Journal:  Biochem Soc Symp       Date:  1999

Review 7.  Aging and genome maintenance: lessons from the mouse?

Authors:  Paul Hasty; Judith Campisi; Jan Hoeijmakers; Harry van Steeg; Jan Vijg
Journal:  Science       Date:  2003-02-28       Impact factor: 47.728

Review 8.  Cockayne syndrome: unusual neuropathological findings and review of the literature.

Authors:  D Soffer; H W Grotsky; I Rapin; K Suzuki
Journal:  Ann Neurol       Date:  1979-10       Impact factor: 10.422

9.  Ultraviolet-induced mutations in Cockayne syndrome cells are primarily caused by cyclobutane dimer photoproducts while repair of other photoproducts is normal.

Authors:  C N Parris; K H Kraemer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

10.  MRI in Cockayne syndrome type I.

Authors:  E Boltshauser; C Yalcinkaya; W Wichmann; F Reutter; A Prader; A Valavanis
Journal:  Neuroradiology       Date:  1989       Impact factor: 2.804

View more
  33 in total

Review 1.  Nucleotide excision repair deficient mouse models and neurological disease.

Authors:  Laura J Niedernhofer
Journal:  DNA Repair (Amst)       Date:  2008-02-12

Review 2.  Disorders of nucleotide excision repair: the genetic and molecular basis of heterogeneity.

Authors:  James E Cleaver; Ernest T Lam; Ingrid Revet
Journal:  Nat Rev Genet       Date:  2009-10-07       Impact factor: 53.242

Review 3.  Xeroderma pigmentosum: overview of pharmacology and novel therapeutic strategies for neurological symptoms.

Authors:  Rosella Abeti; Anna Zeitlberger; Colm Peelo; Hiva Fassihi; Robert P E Sarkany; Alan R Lehmann; Paola Giunti
Journal:  Br J Pharmacol       Date:  2019-01-23       Impact factor: 8.739

4.  Cockayne syndrome-derived neurons display reduced synapse density and altered neural network synchrony.

Authors:  Alexandre T Vessoni; Roberto H Herai; Jerome V Karpiak; Angelica M S Leal; Cleber A Trujillo; Annabel Quinet; Lucymara F Agnez Lima; Carlos F M Menck; Alysson R Muotri
Journal:  Hum Mol Genet       Date:  2016-01-10       Impact factor: 6.150

5.  Neuroimaging in Cockayne syndrome.

Authors:  M Koob; V Laugel; M Durand; H Fothergill; C Dalloz; F Sauvanaud; H Dollfus; I J Namer; J-L Dietemann
Journal:  AJNR Am J Neuroradiol       Date:  2010-06-03       Impact factor: 3.825

6.  Dolphin genome provides evidence for adaptive evolution of nervous system genes and a molecular rate slowdown.

Authors:  Michael R McGowen; Lawrence I Grossman; Derek E Wildman
Journal:  Proc Biol Sci       Date:  2012-06-27       Impact factor: 5.349

Review 7.  Cockayne syndrome: Clinical features, model systems and pathways.

Authors:  Ajoy C Karikkineth; Morten Scheibye-Knudsen; Elayne Fivenson; Deborah L Croteau; Vilhelm A Bohr
Journal:  Ageing Res Rev       Date:  2016-08-06       Impact factor: 10.895

Review 8.  DNA damage in the oligodendrocyte lineage and its role in brain aging.

Authors:  Kai-Hei Tse; Karl Herrup
Journal:  Mech Ageing Dev       Date:  2016-05-26       Impact factor: 5.432

Review 9.  Peptide Hormone Regulation of DNA Damage Responses.

Authors:  Vera Chesnokova; Shlomo Melmed
Journal:  Endocr Rev       Date:  2020-07-01       Impact factor: 19.871

10.  Cockayne syndrome group B (Csb) and group a (Csa) deficiencies predispose to hearing loss and cochlear hair cell degeneration in mice.

Authors:  A Paul Nagtegaal; Robert N Rainey; Ingrid van der Pluijm; Renata M C Brandt; Gijsbertus T J van der Horst; J Gerard G Borst; Neil Segil
Journal:  J Neurosci       Date:  2015-03-11       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.